Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$938K Sell
7,298
-10
-0.1% -$1.17K 0.2% 82
2026
Q1
$879K Buy
7,308
+1,898
+35% +$219K 0.22% 76
2025
Q4
$569K Buy
5,410
+398
+8% +$37.4K 0.15% 96
2025
Q3
$421K Buy
5,012
+307
+7% +$25.3K 0.12% 112
2025
Q2
$372K Sell
4,705
-353
-7% -$28.1K 0.12% 119
2025
Q1
$454K Sell
5,058
-971
-16% -$90.7K 0.17% 88
2024
Q4
$600K Buy
+6,029
New +$622K 0.23% 67

Other funds holding MRK

May Hill Capital's MRK Position: Q2 2026 in Review

May Hill Capital reduced its Merck (MRK) stake by 0.14% in Q2 2026, selling an estimated $1.17K and leaving 7,298 shares worth $938K. The position accounts for 0.2% of the portfolio, ranked #82.

May Hill Capital first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • May Hill Capital held 7,298 shares of Merck worth $938K as of Q2 2026.
  • May Hill Capital sold 10 Merck shares in Q2 2026, an estimated $1.17K.
  • Merck made up 0.2% of May Hill Capital's portfolio in Q2 2026, its #82 holding.
  • May Hill Capital first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.